Vertex Pharmaceuticals
VRTX
#181
Rank
$113.43 B
Marketcap
$446.54
Share price
0.76%
Change (1 day)
-7.90%
Change (1 year)

Operating Margin for Vertex Pharmaceuticals (VRTX)

Operating Margin as of April 2026 (TTM): 38.68%

According to Vertex Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 38.68%. At the end of 2025 the company had an Operating Margin of 38.69%.

Operating Margin history for Vertex Pharmaceuticals from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202538.69%1615.73%
20242.25%-94.92%
202344.38%-6.36%
202247.39%31.47%
202136.05%-28.23%
202050.23%49.89%
201933.51%70.13%
201819.70%-3224.19%
2017-0.63%-84.07%
2016-3.96%-92.68%
2015-54.03%-57.32%
2014-126.61%145.11%
2013-51.65%-2565.28%
20122.10%-51.1%
20114.28%-100.81%
2010-526.35%-16.49%
2009-630.27%141.32%
2008-261.18%25.96%
2007-207.36%99.05%
2006-104.17%18.25%
2005-88.10%-34.06%
2004-133.60%-46.51%
2003-249.78%59.99%
2002-156.12%15.7%
2001-134.94%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58%-10.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
10.78%-72.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
33.27%-13.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
32.40%-16.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
19.35%-49.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-116.14%-400.26%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.